2022-25022. National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Resource Related Research Projects (R24 Clinical Trial Not Allowed).

    Date: December 12, 2022.

    Time: 9:30 a.m. to 2:00 p.m.

    Agenda: To review and evaluate grant applications.

    Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G11A, Rockville, MD 20892 (Virtual Meeting).

    Contact Person: J. Bruce Sundstrom, Ph.D. Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G11A Rockville, MD 20852 240-669-5045 sundstromj@niaid.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

    Start Signature

    Dated: November 10, 2022.

    Tyeshia M. Roberson-Curtis,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2022-25022 Filed 11-16-22; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
11/17/2022
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
2022-25022
Dates:
December 12, 2022.
Pages:
69036-69036 (1 pages)
PDF File:
2022-25022.pdf